Phase 2 Trial of SC Versus IV Anakinra to Prevent CRS and Neurotoxicity in LBCL Patients Receiving Lisocabtagene Maraleucel: Final Analysis and Comparison to Historical ControlEmily C. Liang, Jordan Gauthier, Valentin Ortiz-Maldonado et al.|Transplantation and Cellular Therapy|2025Cited by 0